363 filings
6-K
TLSA
Tiziana Life Sciences Ltd
23 Apr 24
Report of Foreign Private Issuer
7:00am
6-K
TLSA
Tiziana Life Sciences Ltd
22 Apr 24
Tiziana Life Sciences Announces Additional Clinical Improvements Among Multiple Sclerosis Patients in its Expanded Access Program
10:10am
6-K
TLSA
Tiziana Life Sciences Ltd
19 Apr 24
Report of Foreign Private Issuer
7:00am
6-K
TLSA
Tiziana Life Sciences Ltd
18 Apr 24
Tiziana Life Sciences Announces New Quantitative PET Imaging Data on Foralumab at the Annual Meeting of the American Academy of Neurology
7:00am
6-K
TLSA
Tiziana Life Sciences Ltd
11 Apr 24
Report of Foreign Private Issuer
7:00am
6-K
9gla6r
5 Mar 24
Tiziana Life Sciences Announces Podium Presentation at AD/PD of Nasal Anti-CD3 in Alzheimer’s Disease
7:00am
6-K
ohbwon1l1 la0ygd8htm
8 Jan 24
Tiziana Life Sciences Announces Updated Clinical and PET Scan Findings for Intranasal Foralumab in Two New Multiple Sclerosis Patients
7:00am
6-K
qgljoutjo03gpv akgp
5 Jan 24
Report of Foreign Private Issuer
9:30am
6-K
n1s5nwz4x2i3392ad6
5 Jan 24
Report of Foreign Private Issuer
7:00am
6-K
dn6yhb ab5qffpk
29 Dec 23
Updated Interim Results for the Six Months Ended 30 June 2023
4:30pm
6-K
klisk
19 Dec 23
Report of Foreign Private Issuer
7:00am
6-K
2iwzeb4b5
4 Dec 23
Report of Foreign Private Issuer
7:00am
6-K
ger5cabuz6jkkw11g
1 Dec 23
To Be Held As a “Remote Meeting” Only
9:00am
6-K
3aal20f3m gdoxs9hi0
30 Nov 23
Tiziana Life Sciences Announces Foralumab Dosing of Four New Patients in the Expanded Access Program for Multiple Sclerosis
7:08am
6-K
38avq rvhvqcvhx
1 Nov 23
Report of Foreign Private Issuer
7:00am
6-K
c70pb cdq
18 Oct 23
Tiziana Life Sciences Announces Allowance By FDA For At-Home Dosing Of Intranasal Foralumab For Multiple Sclerosis Treatment
7:12am
6-K
i9r90h ke29ah4cu05b
16 Oct 23
Tiziana Life Sciences Announces Positive Six-Month Clinical Results in Multiple Sclerosis Patients Treated with Intranasal Foralumab
7:00am
6-K
h5m1vapx6pv5fx7
13 Oct 23
Report of Foreign Private Issuer
7:00am
6-K
yyar1w6wg3if8
11 Oct 23
Report of Foreign Private Issuer
7:00am
6-K
5zwr1 15n70
26 Sep 23
Report of Foreign Private Issuer
7:00am